Literature DB >> 11227762

Inhibition of growth of cultured Babesia microti by serum and macrophages in the presence or absence of T cells.

D Chen1, D B Copeman, G W Hutchinson, J Burnell.   

Abstract

Serum and macrophages from the acute-phase (days 12-14 p.i.) and recovery-phase (days 23-25 p.i.) of infection of mice with Babesia microti were analyzed for their ability to inhibit the in vitro growth of B. microti in the presence or absence of T cells. Recovery-phase serum was inhibitory to the growth of B. microti, whereas, acute-phase serum had no inhibitory effects. Both acute- and recovery-phase macrophages inhibited B. microti growth. The co-culture of acute- but not recovery-phase T cells with macrophages from uninfected control mice was inhibitory to the growth of B. microti. Growth of B. microti was also inhibited in cultures containing macrophages from uninfected control mice plus culture supernatant fluid from acute-phase but not recovery-phase T cells. The supernatant fluid from B. microti cultures with acute-phase T cells contained IFN-gamma detected by a sandwich ELISA, whereas cultures with control T cells or recovery phase T cells did not. Results of the present study suggest the likelihood of a protective role against B. microti in mice for antibody which appeared in recovery-phase serum and for macrophages activated by IFN-gamma from acute-phase T cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11227762     DOI: 10.1016/s1383-5769(99)00022-7

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  5 in total

1.  Development of specific immunoglobulin Ga (IgGa) and IgGb antibodies correlates with control of parasitemia in Babesia equi Infection.

Authors:  Cristina W Cunha; Travis C McGuire; Lowell S Kappmeyer; Stephen A Hines; A Marianela Lopez; Odir A Dellagostin; Donald P Knowles
Journal:  Clin Vaccine Immunol       Date:  2006-02

2.  Cellular immunity, but not gamma interferon, is essential for resolution of Babesia microti infection in BALB/c mice.

Authors:  Michael L Clawson; Natalia Paciorkowski; T V Rajan; Carson La Vake; Conny Pope; Morgan La Vake; Stephen K Wikel; Peter J Krause; Justin D Radolf
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

3.  Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone.

Authors:  Lauren A Lawres; Aprajita Garg; Vidya Kumar; Igor Bruzual; Isaac P Forquer; Isaline Renard; Azan Z Virji; Pierre Boulard; Eduardo X Rodriguez; Alexander J Allen; Sovitj Pou; Keith W Wegmann; Rolf W Winter; Aaron Nilsen; Jialing Mao; Douglas A Preston; Alexia A Belperron; Linda K Bockenstedt; David J Hinrichs; Michael K Riscoe; J Stone Doggett; Choukri Ben Mamoun
Journal:  J Exp Med       Date:  2016-06-06       Impact factor: 14.307

4.  Age-Related Differential Stimulation of Immune Response by Babesia microti and Borrelia burgdorferi During Acute Phase of Infection Affects Disease Severity.

Authors:  Vitomir Djokic; Shekerah Primus; Lavoisier Akoolo; Monideep Chakraborti; Nikhat Parveen
Journal:  Front Immunol       Date:  2018-12-07       Impact factor: 7.561

Review 5.  Treatment of Human Babesiosis: Then and Now.

Authors:  Isaline Renard; Choukri Ben Mamoun
Journal:  Pathogens       Date:  2021-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.